Motivation: Obesity is an alarming global public health priority with well-established links to serious diseases including type 2 diabetes, coronary heart disease, stroke, cancer, and chronic obstructive pulmonary disease. While the use of GLP-1s to treat obesity has had dramatic uptake, there is still a tremendous need for more effective therapies with greater weight loss potential.